GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Ending Cash Position

Serina Therapeutics (Serina Therapeutics) Ending Cash Position : $8.76 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Ending Cash Position?

Serina Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 was $8.76 Mil.

Serina Therapeutics's quarterly Ending Cash Position increased from Dec. 2022 ($0.53 Mil) to Jun. 2023 ($8.72 Mil) and increased from Jun. 2023 ($8.72 Mil) to Mar. 2024 ($8.76 Mil).

Serina Therapeutics's annual Ending Cash Position increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.32 Mil) and increased from Dec. 2021 ($0.32 Mil) to Dec. 2022 ($0.53 Mil).

Serina Therapeutics Ending Cash Position Historical Data

The historical data trend for Serina Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Ending Cash Position Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22
Ending Cash Position
0.32 0.53

Serina Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Mar24
Ending Cash Position - 0.70 0.53 8.72 8.76

Serina Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Serina Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.315+0.217
=0.53

Serina Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=7.619+1.137
=8.76

Serina Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics (Serina Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Ending Cash Position
Comparable Companies
Traded in Other Exchanges
2BO:Germany
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Website
https://www.serinatherapeutics.com
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines

From GuruFocus

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse� for Advanced Parkinson's Disease

By Marketwired • 05-15-2024